SCHEMBL2203348

SCHEMBL2203348

CCCN(CCC)CCCCC(N)c1ccc(CN=Cc2cccc([N+](=O)[O-])c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ALDH1A1 P00352 8/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPK1 P28482 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 2/20 0.38
RECQL P46063 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.37
RAB9A P51151 1/20 0.36
PTGS2 P35354 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2203351 0.81 ALDH1A1 (0.43) CA1CA2ALDH1A1NPSR1USP2
SCHEMBL12426467 0.78 ALDH1A1 (0.43) CA1CA2ALDH1A1NPSR1USP2
SCHEMBL2205031 0.77 ALDH1A1 (0.41) CA1CA2ALDH1A1NPSR1USP2
SCHEMBL2205028 0.77 ALDH1A1 (0.42) CA1CA2ALDH1A1NPSR1USP2
SCHEMBL2205034 0.77 ALDH1A1 (0.42) CA1CA2ALDH1A1NPSR1USP2
SCHEMBL2202381 0.76 CYP1A2 (0.40) CA1CA2ALDH1A1SMN1; SMN2TDP1
SCHEMBL2202960 0.75 CA2 (0.37) CA1CA2LMNA
SCHEMBL2203375 0.72 KDM4E (0.34) CA1ALDH1A1NPSR1MAPK1L3MBTL1
SCHEMBL2203507 0.71 KDM4E (0.33) ALDH1A1MAPT
SCHEMBL2204052 0.71 CXCR4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977512-B2 Amine derivative, and production method and use thereof KUREHA CORPORATION (JP) 2011-07-12 US disclosed
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof KUREHA CORPORATION 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293951-A1 Amin Derivative, and Production Method and Use Thereof BCAT2, BCAT1, MRPL9 CA1 3598/4885CA2 1761/4885ALDH1A1 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.